Food and Drug Regulations, C.R.C., c. 870

Section C.11.006

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.11.006 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) The initial public health official must ensure that the drug bears a label or is accompanied by a document that clearly sets out the following information in English and French: (a) the name and civic address of the drug’s manufacturer; (b) a statement that the Minister has authorized the sale of the drug to address the emergency, event or incident described in the authorization; (c) a statement that the drug is to be used only for the use described in the authorization; (d) the drug’s brand name, if any, and either its proper name, common name and chemical name or its identifying name, code, number or mark; (e) the drug’s medicinal ingredients; (f) the drug’s strength; (g) the drug’s dosage form; (h) the drug’s recommended dosage and route of administration; (i) the drug’s lot number, if known; (j) all warnings and precautions in respect of the use of the drug, if any; (k) the drug’s expiration date, or, if there is no expiration date, the stability testing date or the date on which the drug should be retested, as specified by the manufacturer; (l) the drug’s recommended storage conditions; and (m) the net contents of the drug’s container, in terms of the weight, volume, size or number of units of the drug in the container. (2) Any subsequent public health official must ensure that the drug bears the label or is accompanied by the document. (3) If the initial public health official becomes aware of a change to any of the information referred to in paragraph (1)(a), (h), (j), (k) or (l), they must (a) ensure that the information on the drug’s label or in the accompanying document is updated; and (b) notify of the change, in writing and without delay, any person to whom they have sold any quantity of the drug. (4) If the person notified under paragraph (3)(b) is a subsequent public health official, they must notify of the change, in writing and without delay, any person to whom they have sold any quantity of the drug. (5) Any person who is notified under paragraph (3)(b) or subsection (4) must ensure that the updated information accompanies, in writing, any quantity of the drug that remains in their possession.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.